Stimulant use and comorbid tic disorders in the pediatric population: Clinical considerations and treatment implications

---

Dr. Brandon Krout
 

Colquitt Regional Medical Center, United State

: Int J Ment Health Psychiatry

Abstract

---

Attention-Deficit/Hyperactivity Disorder (ADHD) is frequently treated with stimulant medications such as methylphenidate and amphetamines. However, concerns persist regarding the potential exacerbation or onset of tic disorders in children receiving stimulant therapy which often leads to hesitancy to begin or continue treatment. The U.S. Food and Drug Administration (FDA) has issued warnings about stimulant-induced tics, included in the packaging of dextroamphetamine (Adderall). There is conflicting evidence concerning the worsening of tics as a side effect to simulants, highlighting the need for careful clinical evaluation in patients with comorbid tic disorders prior to starting medication regimens. This study examines the relationship between stimulant use and tic disorders to inform clinical decision-making based on current published data.

Biography

---

Leading psychologist Brandon Krout is a principal investigator in the fields of psychology and clinical science. He wants to continue with subspeciality research because he is really interested in paediatric psychiatry. In order to raise awareness of clinical issues and treatment implications in the paediatric population, he published this case report.